FAILURE OF SOMATOSTATIN TO CORRECT MANIFEST DIABETIC KETOACIDOSIS
- 31 January 1976
- journal article
- Published by Elsevier in The Lancet
- Vol. 307 (7953) , 215-218
- https://doi.org/10.1016/s0140-6736(76)91338-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- ROLE OF GLUCAGON AND OTHER HORMONES IN DEVELOPMENT OF DIABETIC KETOACIDOSISThe Lancet, 1975
- The Effect of Somatostatin on the Rise of Growth Hormone and Glucagon Secretion Induced by Arginine and L-Dopa in Diabetic PatientsScandinavian Journal of Clinical and Laboratory Investigation, 1975
- THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUSThe Lancet, 1975
- EFFECTS OF GROWTH-HORMONE RELEASE-INHIBITING HORMONE ON CIRCULATING GLUCAGON, INSULIN, AND GROWTH HORMONE IN NORMAL, DIABETIC, ACROMEGALIC, AND HYPOPITUITARY PATIENTSThe Lancet, 1974
- Some Actions of Growth Hormone Release Inhibiting FactorBMJ, 1973
- SMALL DOSES OF INTRAMUSCULAR INSULIN IN THE TREATMENT OF DIABETIC " COMA "The Lancet, 1973
- Diabetic coma: Serum growth hormone before and during treatmentDiabetologia, 1973
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973
- Notes on the Glucose Oxidase MethodScandinavian Journal of Clinical and Laboratory Investigation, 1967
- Eine neue Bestimmung der Neutralfette im Blutserum und GewebeKlinische Wochenschrift, 1966